Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study. - Mao, Chenyu; Xiong, Anwen; Qian, Jiong; Wang, Wenxiang; Liu, Ying; Zhang, Tao; Wu, Zhihai; Ni, Haiqing; Lu, Jia; Long, Sixiang; Zhao, Li; Chen, Yuling; et al. (Journal of Hematology & Oncology, 2024)